Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
4.660
+0.300 (6.88%)
At close: Oct 8, 2025, 4:00 PM EDT
4.687
+0.027 (0.57%)
After-hours: Oct 8, 2025, 7:07 PM EDT
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $9.42 million as of October 8, 2025. Its market cap has increased by 175.18% in one year.
Market Cap
9.42M
Enterprise Value
8.23M
1-Year Change
175.18%
Ranking
Category
Stock Price
$4.66
Market Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has increased from $5.88M to $9.42M, an increase of 60.23%. That is a compound annual growth rate of 6.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 8.81M | 157.47% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | 11.03M | 19.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |